The same authors showed that blocking the activity of pulmonary sensory neurons and the subsequent release of substance P during allergic asthma was sufficient to reduce allergy-induced goblet cell hyperplasia and hypersecretion of Muc5AC [22], a mucin that contributes to airway hyperactivity [42]. Here, TAC1 is linked to allergic disease.